These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 8585721

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.
    Nagy K, Young M, Baboonian C, Merson J, Whittle P, Oroszlan S.
    J Virol; 1994 Feb; 68(2):757-65. PubMed ID: 8289379
    [Abstract] [Full Text] [Related]

  • 25. Native oligodeoxynucleotides specifically active against human immunodeficiency virus type 1 in vitro: a G-quartet-driven effect?
    Tondelli L, Colonna FP, Garbesi A, Zanella S, Marongiu ME, Corrias S, Loi AG, La Colla P.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2034-8. PubMed ID: 8878576
    [Abstract] [Full Text] [Related]

  • 26. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
    Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R.
    J Virol; 1995 May; 69(5):2729-36. PubMed ID: 7535863
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.
    Lee DS, Jung KE, Yoon CH, Lim H, Bae YS.
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4110-20. PubMed ID: 16189087
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro.
    Bilello JA, Bilello PA, Kort JJ, Dudley MN, Leonard J, Drusano GL.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2523-7. PubMed ID: 8585738
    [Abstract] [Full Text] [Related]

  • 32. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C, Yelle J, Sauve G, Thierry AR.
    AAPS PharmSci; 2002 Nov; 4(2):E9. PubMed ID: 12102618
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
    Cushman M, Golebiewski WM, McMahon JB, Buckheit RW, Clanton DJ, Weislow O, Haugwitz RD, Bader JP, Graham L, Rice WG.
    J Med Chem; 1994 Sep 16; 37(19):3040-50. PubMed ID: 7932526
    [Abstract] [Full Text] [Related]

  • 34. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
    Weichold FF, Lisziewicz J, Zeman RA, Nerurkar LS, Agrawal S, Reitz MS, Gallo RC.
    AIDS Res Hum Retroviruses; 1995 Jul 16; 11(7):863-7. PubMed ID: 7546914
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS, Fliakas-Boltz V, Bader JP, Buckheit RW.
    Leukemia; 1995 Oct 16; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.
    Souza TM, Cirne-Santos CC, Rodrigues DQ, Abreu CM, Tanuri A, Ferreira VF, Marques IP, de Souza MC, Fontes CF, Frugulhetti IC, Bou-Habib DC.
    Curr HIV Res; 2008 May 16; 6(3):209-17. PubMed ID: 18473784
    [Abstract] [Full Text] [Related]

  • 39. Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.
    Robinson WE, Reinecke MG, Abdel-Malek S, Jia Q, Chow SA.
    Proc Natl Acad Sci U S A; 1996 Jun 25; 93(13):6326-31. PubMed ID: 8692814
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.
    Yusa K, Oh-hara T, Tsukahara S, Baba K, Taniguchi M, Kozawa M, Takeuchi S, Hara H, Tsuruo T.
    Antiviral Res; 1994 Sep 25; 25(1):57-66. PubMed ID: 7529015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.